Cannabis Users Face Growing 'Scromiting' Health Concern

Emergency room visits for Cannabinoid Hyperemesis Syndrome—a condition causing severe vomiting in regular cannabis users—have increased in states with legal marijuana, according to recent medical data.

The condition, nicknamed "scromiting" for the screaming that sometimes accompanies intense nausea, remains rare but appears to be becoming more common as cannabis use increases and products become more potent.

"We're seeing more cases as the average THC content in products rises," said Dr. Kenneth Taylor, a cannabinoid researcher. "Patients often don't associate their symptoms with cannabis because it's counterintuitive."

What Is CHS?

Cannabinoid Hyperemesis Syndrome causes cyclical episodes of severe nausea and vomiting in some long-term cannabis users. The symptoms are paradoxical because cannabis is typically used to treat nausea, not cause it.

Many patients report temporary relief from hot showers or baths, a distinctive symptom that helps doctors diagnose the condition. But the only proven long-term solution is stopping cannabis use entirely.

The exact mechanism causing CHS isn't fully understood. Researchers believe it may involve how cannabinoids interact with receptors in the digestive system over time, though high-potency products appear to increase risk.

Rising Incidence

Emergency departments in Colorado, California, and other legal states have reported increases in CHS cases since recreational legalization. The rise correlates with increased cannabis use and the availability of high-THC concentrates and edibles.

Many cases likely go undiagnosed because patients don't mention their cannabis use to doctors, or physicians don't consider CHS as a possible diagnosis. As awareness grows among medical professionals, diagnosis rates are expected to increase further.

Public Health Implications

The condition highlights knowledge gaps about cannabis health effects—particularly around chronic, high-dose use of potent products. Most cannabis research has focused on occasional or moderate use of traditional flower products.

For the cannabis industry, CHS represents a consumer education challenge. Companies and regulators will need to develop guidance around product potency, consumption patterns, and potential risks—similar to alcohol industry competition practices around responsible consumption.

This article is based on original reporting by Boston Herald.